Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis.
Won Kyeong JeonJeehoon KangHyo-Soo KimKyung Woo ParkPublished in: Journal of lipid and atherosclerosis (2021)
As add-on therapy to metformin, there were no significant differences in all-cause mortality and cardiovascular mortality between DPP4 inhibitors and SUs.